» Articles » PMID: 39345735

Application Potential of Albendazole As an Aquatic Animal Drug Based on Its Safety, Efficacy, and Residue Profiles

Overview
Journal Toxicol Res
Specialty Toxicology
Date 2024 Sep 30
PMID 39345735
Authors
Affiliations
Soon will be listed here.
Abstract

The number of available drugs for treating aquatic animals is insufficient, given the occurrence of a variety of parasites and difficulties in developing appropriate treatments, such as vaccines or immunostimulants. Consequently, repurposing livestock drugs for treating aquatic animals is a viable alternative. Several studies have demonstrated that albendazole (ABZ) is a good anthelmintic for humans and animals such as ruminants, poultry, and honeybees. Therefore, we investigated the toxicological studies, metabolic and residue depletion studies, and efficacy trials of ABZ in aquatic animals to identify its application potential as a drug for aquatic animals. ABZ was depleted within 24 h in the muscle tissues of hybrid striped bass, rainbow trout, and tilapia. In muscle tissue with adhering skin obtained from tilapia and largemouth bass, a significant quantity of the amino-sulfone metabolite of ABZ (ABZ-SONH) was present, while no ABZ-SONH was detected in hybrid striped bass, channel catfish, and patinga. Fish exposed only to high doses of ABZ showed reduced red blood cell counts and hemoglobin levels and increased lymphocytes. Such signs of toxicity have also been observed in human patients and animal studies. At a dose of 100 mg/L, ABZ showed 100% efficacy in eels. In addition, albendazole sulfoxide (ABZSO) demonstrated efficacies of 96.1% and 100% in pirapatinga and ray-finned fish, respectively, at a dose 500 mg/L. ABZ was also highly effective in treating an intracellular parasite in white shrimp. The application of ABZ in aquatic animals under the low-dose and short-term conditions is considered a reasonable solution to manage parasite infections. The types and residual periods of degradation products differed among fish species, suggesting dissimilar metabolic pathways. With a high demand for new alternative veterinary drugs in aquaculture by fish farmers, this review offers important evidence for considering the use of ABZ in Korean farmed fish, taking food safety issues into account.

References
1.
Harm T, Radke S, Burns L, Schrunk D . Enteropathy and bone marrow hypoplasia associated with presumptive albendazole toxicosis in a juvenile Boer goat. J Vet Diagn Invest. 2022; 34(6):1015-1019. PMC: 9597350. DOI: 10.1177/10406387221121122. View

2.
Shaikh B, Rummel N, Gieseker C, Reimschuessel R . Metabolism and depletion of albendazole in the muscle tissue of channel catfish following oral treatment. J Vet Pharmacol Ther. 2006; 29(6):525-30. DOI: 10.1111/j.1365-2885.2006.00799.x. View

3.
Portela A, Silveira J, Damaceno M, da Silva A, de Jesus R, Pilarski F . Food safety evaluation for the use of albendazole in fish: residual depletion profile and withdrawal period estimation. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2020; 37(4):596-606. DOI: 10.1080/19440049.2020.1719285. View

4.
Pulkkinen K, Ketola T, Laakso J, Mappes J, Sundberg L . Rich resource environment of fish farms facilitates phenotypic variation and virulence in an opportunistic fish pathogen. Evol Appl. 2022; 15(3):417-428. PMC: 8965373. DOI: 10.1111/eva.13355. View

5.
Tang K, Pantoja C, Redman R, Han J, Tran L, Lightner D . Development of in situ hybridization and PCR assays for the detection of Enterocytozoon hepatopenaei (EHP), a microsporidian parasite infecting penaeid shrimp. J Invertebr Pathol. 2015; 130:37-41. DOI: 10.1016/j.jip.2015.06.009. View